Michael Craig Pine - Net Worth and Insider Trading
Michael Craig Pine Net Worth
The estimated net worth of Michael Craig Pine is at least $59,361 dollars as of 2024-11-13. Michael Craig Pine is the Chief Corp Dev.&Strat. Officer of EyePoint Pharmaceuticals Inc and owns about 5,343 shares of EyePoint Pharmaceuticals Inc (EYPT) stock worth over $59,361. Details can be seen in Michael Craig Pine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Craig Pine has not made any transactions after 2023-12-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Craig Pine
Michael Craig Pine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Craig Pine owns 1 companies in total, including EyePoint Pharmaceuticals Inc (EYPT) .
Click here to see the complete history of Michael Craig Pine’s form 4 insider trades.
Insider Ownership Summary of Michael Craig Pine
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals Inc | 2023-12-04 | Chief Corp Dev.&Strat. Officer |
Michael Craig Pine Latest Holdings Summary
Michael Craig Pine currently owns a total of 1 stock. Michael Craig Pine owns 5,343 shares of EyePoint Pharmaceuticals Inc (EYPT) as of December 4, 2023, with a value of $59,361.
Latest Holdings of Michael Craig Pine
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals Inc | 2023-12-04 | 5,343 | 11.11 | 59,361 |
Holding Weightings of Michael Craig Pine
Michael Craig Pine Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Craig Pine has made a total of 3 transactions in EyePoint Pharmaceuticals Inc (EYPT) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in EyePoint Pharmaceuticals Inc is the sale of 45,000 shares on December 4, 2023, which brought Michael Craig Pine around $990,000.
Insider Trading History of Michael Craig Pine
- 1
Michael Craig Pine Trading Performance
GuruFocus tracks the stock performance after each of Michael Craig Pine's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Craig Pine is -36.98%. GuruFocus also compares Michael Craig Pine's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Craig Pine within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Craig Pine's insider trading performs compared to the benchmark.
Performance of Michael Craig Pine
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.59 | | | | | |
| Relative Return to S&P 500(%) | -1.67 | | | | | |
Michael Craig Pine Ownership Network
Ownership Network List of Michael Craig Pine
Ownership Network Relation of Michael Craig Pine
Michael Craig Pine Owned Company Details
What does EyePoint Pharmaceuticals Inc do?
Who are the key executives at EyePoint Pharmaceuticals Inc?
Michael Craig Pine is the Chief Corp Dev.&Strat. Officer of EyePoint Pharmaceuticals Inc. Other key executives at EyePoint Pharmaceuticals Inc include director & President and CEO Nancy Lurker , SVP & Chief Commercial Officer David Scott Jones , and Chief Medical Officer Dario A. Paggiarino .
EyePoint Pharmaceuticals Inc (EYPT) Insider Trades Summary
Over the past 18 months, Michael Craig Pine made 2 insider transaction in EyePoint Pharmaceuticals Inc (EYPT) with a net sale of 91,000. Other recent insider transactions involving EyePoint Pharmaceuticals Inc (EYPT) include a net sale of 943,936 shares made by Ew Healthcare Partners, L.p. , a net sale of 121,307 shares made by Dario A. Paggiarino , and a net purchase of 4,794,057 shares made by Cormorant Asset Management, Lp .
In summary, during the past 3 months, insiders sold 0 shares of EyePoint Pharmaceuticals Inc (EYPT) in total and bought 23,240 shares, with a net purchase of 23,240 shares. During the past 18 months, 4,229,811 shares of EyePoint Pharmaceuticals Inc (EYPT) were sold and 4,817,297 shares were bought by its insiders, resulting in a net purchase of 587,486 shares.
EyePoint Pharmaceuticals Inc (EYPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
EyePoint Pharmaceuticals Inc Insider Transactions
Michael Craig Pine Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Craig Pine. You might contact Michael Craig Pine via mailing address: C/o Eyepoint Pharmaceuticals, Inc., 480 Pleasant Street, Suite A-210, Watertown Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
